top of page

Accessible | Afforable | Innovation

Our CAR-T Cell Therapies are available at major cancer hospitals across India

We are committed to connecting patients, caregivers, and healthcare providers in the cell therapy community to the centers where our therapies are accessible.


Partner Hospitals are provided below by regional zones in India.


NexCAR19 is commercially approved in India for the treatment of B-lymphomas and B-Acute Lymphoblastic Leukaemia where one or more lines of treatment have failed or have been rendered inadequate or insufficient to render a response.

Contact us to know more

bottom of page